Heartburn drug Zantac recalled in Canada, U.S. over contamination fears | CBC News
Drugmaker Sanofi is recalling its over-the-counter heartburn drug Zantac in the U.S. and Canada because of possible contamination.
The French company Friday joined other drugmakers that have recently recalled their versions of the popular heartburn and ulcer drug.
In September, the U.S. Food and Drug Administration said a potentially cancer-causing chemical had been detected at low levels in prescription and over-the-counter versions of Zantac. The federal agency said consumers could consider taking another heartburn medicine or contact their doctor.
Health Canada also said it was investigating the possible presence of a carcinogen in some ranitidine drugs available by prescription and over-the-counter. The agency issued a precautionary request last month for companies to stop distributing the medication.
Several drugstore chains have already removed Zantac and generic versions from store shelves.
In September, the FDA found low levels of of a cancer-causing chemical NDMA in Zantac and its generic ranitidine NDMA is linked to colorectal, gastric and kidney cancers in animal studies Detection of NDMA in blood pressure
The French drug maker Sanofi said Friday it would be voluntarily recalling Zantac in the U.S. and Canada, as the Food and Drug Administration investigates a potentially dangerous contaminant detected in the drug. The company
A French pharmaceutical company is recalling heartburn drug Zantac after the U.S. Food and Drug Administration found it contained unsafe levels of a chemical linked to cancer. Sanofi, the latest pharmaceutical firm to pull the drug,
The drugmaker Sanofi announced Friday that it is recalling the heartburn drug Zantac in the United States and Canada because of concerns it could contain low levels of a cancer-causing chemical. The company said
Sanofi SA said on Friday it would recall popular heartburn medicine Zantac in the United States and Canada, after the medicines were linked with a probable cancer-causing impurity. The French drugmaker said it was working with
The French drug maker Sanofi said Friday that it was recalling the over-the-counter heartburn drug Zantac in the United States and Canada, a month after the Food and Drug Administration first alerted the public that
by: WHTM Staff Posted: / Updated: A box of Maximum Strength Zantac tablets is shown at a pharmacy, Monday, Sept. 30, 2019, in Miami Beach, Fla. CVS has halted sales of the popular heartburn treatment
NEW YORK (Reuters) - Sanofi SA said on Friday it would recall popular heartburn medicine Zantac in the United States and Canada, after the medicines were linked with a probable cancer-causing impurity.
More News in Health
Johnson & Johnson is recalling a shipment of baby powder after the Food and Drug Administration discovered evidence of asbestos, the company said on Friday. In a test, the regulator found trace levels of chrysotile asbestos
Three young siblings in Ohio are among thousands of people across the country who are in need of bone marrow transplants.Three-year-old Ava Langenhop, her 2-year-old sister, Olivia, and their 2-week-old brother, Landon, have all been
Gentry Burns Port Orange, Florida man arrested after having sex with three different women while declining to inform them he is HIV positive. More victims feared. A Volusia County, Florida man has been
A woman and child wait to receive the Ebola vaccination in Goma, Democratic Republic of the Congo. Photo by: REUTERS / Baz Ratner MANILA - The Ebola outbreak in the Democratic Republic of the
CANTON, Ohio - Thousands of people across the United States are in need of a bone marrow transplant. Three of them happen to be young siblings who live in Canton. Three-year-old Ava Langenhop, her two-year-old sister,
New cases are down to 15 a week from a high of 128 in April, but outbreaks are still popping up in remote and dangerous mining areas. Image Health workers dressed in protective gear beginning